Survival and fracture risk with radium-223 therapy in metastatic castrate-resistant prostate cancer (mCRPC): A real-world analysis

被引：0
|
作者：
Zhang, Hanbo
Graham, Jeffrey
Czaykowski, Piotr
Gingerich, Joel Roger
Bybel, Bohdan
Dawe, David E.
机构：
[1] Univ Manitoba, Med Oncol & Hematol, CancerCare Manitoba, Winnipeg, MB, Canada
[2] Univ Manitoba, Winnipeg Hlth Sci Ctr, Nucl Med, Winnipeg, MB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.50
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [1] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [2] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [3] Radium-223 in the treatment of metastatic castrate-resistant prostate cancer: A real-world Irish experience
    Peters, Niamh
    Gaffney, John
    Connolly, Emma
    Bambury, Richard
    Power, Derek Gerard
    Kelly, Paul J.
    Jamaluddin, Muhammad Faisal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] Radium-223 for Metastatic Castrate-Resistant Prostate Cancer
    Sindhu, Kunal K.
    Nehlsen, Anthony D.
    Stock, Richard G.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2022, 12 (04) : 312 - 316
  • [5] Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
    Modi, Dipenkumar
    Hwang, Clara
    Mamdani, Hirva
    Kim, Seongho
    Gayar, Hesham
    Vaishampayan, Ulka
    Joyrich, Richard
    Heath, Elisabeth I.
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 373 - 380
  • [6] Real-World Utilization And Outcomes Of Radium-223 In The Treatment Of Metastatic Castrate Resistant Prostate Cancer
    Li, R.
    Dandapani, S. V.
    Amini, A.
    Pal, S. K.
    Dorff, T. B.
    Lyou, Y.
    Vapiwala, N.
    Wong, J. Y. C.
    Glaser, S. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E885 - E886
  • [7] Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate Cancer
    Parikh, S.
    Murray, L.
    Kenning, L.
    Bottomley, D.
    Din, O.
    Dixit, S.
    Ferguson, C.
    Handforth, C.
    Joseph, L.
    Mokhtar, D.
    White, L.
    Wright, G.
    Henry, A. M.
    [J]. CLINICAL ONCOLOGY, 2018, 30 (09) : 548 - 555
  • [8] Pain Response to Radium-223 in Men With Metastatic Castrate-Resistant Prostate Cancer
    Zhang, I.
    Gilbo, P.
    Cox, B. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E530 - E530
  • [9] Single-Institution Experience With Radium-223 Dichloride (Ra-223) for Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Cox, B. W.
    Wang, L.
    Bradley, T.
    Gu, B.
    Kelley, K.
    Potters, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S470 - S470
  • [10] Clinical response to radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
    Zhang, Isabella
    Gilbo, Philip
    Kohn, Nina
    Cox, Brett
    [J]. PRACTICAL RADIATION ONCOLOGY, 2018, 8 (06) : 452 - 457
12345